Kestra Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Buy |
73,694
+4,854
| +7% | +$339K | 0.03% | 625 |
|
|
2025
Q1 | $5.06M | Sell |
68,840
-13,219
| -16% | -$972K | 0.02% | 575 |
|
|
2024
Q4 | $5.38M | Buy |
82,059
+673
| +0.8% | +$44.1K | 0.03% | 547 |
|
|
2024
Q3 | $6.34M | Sell |
81,386
-14,160
| -15% | -$1.1M | 0.03% | 514 |
|
|
2024
Q2 | $7.45M | Buy |
95,546
+5,558
| +6% | +$433K | 0.04% | 455 |
|
|
2024
Q1 | $6.1M | Buy |
89,988
+11,857
| +15% | +$803K | 0.04% | 460 |
|
|
2023
Q4 | $5.26M | Buy |
78,131
+2,181
| +3% | +$147K | 0.04% | 431 |
|
|
2023
Q3 | $5.14M | Buy |
75,950
+12,330
| +19% | +$835K | 0.05% | 374 |
|
|
2023
Q2 | $4.55M | Sell |
63,620
-7,002
| -10% | -$501K | 0.05% | 399 |
|
|
2023
Q1 | $4.9M | Sell |
70,622
-45,325
| -39% | -$3.15M | 0.05% | 359 |
|
|
2022
Q4 | $7.86M | Buy |
115,947
+11,114
| +11% | +$754K | 0.07% | 302 |
|
|
2022
Q3 | $5.75M | Sell |
104,833
-2,736
| -3% | -$150K | 0.06% | 339 |
|
|
2022
Q2 | $7.11M | Buy |
107,569
+17,070
| +19% | +$1.13M | 0.07% | 281 |
|
|
2022
Q1 | $6M | Buy |
90,499
+8,582
| +10% | +$569K | 0.06% | 322 |
|
|
2021
Q4 | $4.77M | Sell |
81,917
-5,364
| -6% | -$312K | 0.05% | 384 |
|
|
2021
Q3 | $5.24M | Buy |
87,281
+23,465
| +37% | +$1.41M | 0.05% | 371 |
|
|
2021
Q2 | $3.82M | Sell |
63,816
-1,724
| -3% | -$103K | 0.04% | 431 |
|
|
2021
Q1 | $3.26M | Buy |
65,540
+5,870
| +10% | +$292K | 0.04% | 444 |
|
|
2020
Q4 | $2.99M | Buy |
59,670
+18,217
| +44% | +$914K | 0.03% | 465 |
|
|
2020
Q3 | $2.27M | Buy |
+41,453
| New | +$2.27M | 0.04% | 399 |
|